NanoViricides Inc. (NNVC) is priced at $4.59 after the most recent trading session. At the very opening of the session, the stock price was $3.87 and reached a high price of $4.18, prior to closing the session it reached the value of $4.07. The stock touched a low price of $3.85.Recently in News on September 14, 2021, NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development. NanoViricides, Inc. (NYSE Amer.: NNVC) (the “Company”), a global leader in nanomedicines against viruses, announced today that it has completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc. (“TheraCour”). The Company executed a license agreement for the field comprising anti-viral treatments for coronavirus derived human infections with TheraCour Pharma, Inc. on September 8, 2021 (the “Agreement”). You can read further details here
NanoViricides Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.71 on 03/02/21, with the lowest value was $2.91 for the same time period, recorded on 01/04/21.
NanoViricides Inc. (NNVC) full year performance was 2.78%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NanoViricides Inc. shares are logging -47.30% during the 52-week period from high price, and 61.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.85 and $8.71.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 27066654 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NanoViricides Inc. (NNVC) recorded performance in the market was 41.81%, having the revenues showcasing -4.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 48.76M, as it employees total of 17 workers.
The Analysts eye on NanoViricides Inc. (NNVC)
During the last month, 0 analysts gave the NanoViricides Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.97, with a change in the price was noted +0.45. In a similar fashion, NanoViricides Inc. posted a movement of +10.71% for the period of last 100 days, recording 517,285 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NNVC is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of NanoViricides Inc. (NNVC)
Raw Stochastic average of NanoViricides Inc. in the period of last 50 days is set at 61.17%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 66.94%. In the last 20 days, the company’s Stochastic %K was 71.11% and its Stochastic %D was recorded 74.90%.
Considering, the past performance of NanoViricides Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 41.81%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -25.59%, alongside a boost of 2.78% for the period of the last 12 months. The shares increased approximately by 1.24% in the 7-day charts and went down by 3.04% in the period of the last 30 days. Common stock shares were lifted by -4.68% during last recorded quarter.